Skip to main content
Premium Trial:

Request an Annual Quote

OGT Implements Lab901's ScreenTape System for RNA QC

Premium

By Justin Petrone

This article was originally posted on January 11.

Oxford Gene Technology will use Lab901's RNA QC ScreenTape platform to measure the quality of the RNA samples it runs on its microarrays, Lab901 said this week.

ScreenTape is an automated system for gel electrophoresis. Using the system, customers can analyze protein, DNA, and RNA samples by loading a ScreenTape consumable into the Edinburgh, UK-based company's TapeStation instrument. The TapeStation then delivers the ScreenTape Degradation Value, or SDV, a quality metric for total RNA samples.

According to Lab901, its platform eliminates steps such as gel-reagent preparation, chip priming, and chip-vortexing, and avoids problems associated with cross-priming and sample carryover since individual microgels are used for each sample analysis.

John Anson, R&D director at OGT, said in a statement that the UK company adopted Lab901's system to improve the quality of its services business.

"As OGT's microarray R&D and service business grows, we are continually seeking opportunities to increase throughput whilst maintaining the highest standards of data quality," Anson said.

OGT has invested heavily in the services arm of its business in recent years. In 2007, it expanded into a new, 11,800-square-foot facility located in the Begbroke Science Park near Oxford (see BAN 5/29/2007), giving it the space to take on larger projects and add personnel.

The firm's services business was bolstered again when OGT processed 20,000 samples for the Wellcome Trust case Control Consortium's copy number variation study, providing the firm with the resources and experience to take part in larger studies (see BAN 6/2/2009).

Financial details of OGT's deal with Lab901 were not discussed.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.